The Palmoplantar Pustulosis (PPP) industry will relinquish an approximated estimate at a frequency of 4.8% for the projection space of 2020 to 2027 with factor such as increasing number of smokers, increase in cases of metal allergies and increasing women population which are some of the driving factors driving the palmoplantar pustulosis (PPP) market growth.
Increasing number of biologic drug approval for palmoplantar pustulosis (PPP) has propelled the demand of the palmoplantar pustulosis (PPP) market. However, high cost of treatment and lack of diagnosis have decreased the demand of the palmoplantar pustulosis (PPP) market.
The U.S. Palmoplantar Pustulosis (PPP) Market Scenario
According to Data Bridge Market Research, the market for palmoplantar pustulosis (PPP) in the U.S. is growing with the market leader such as Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) which accounts an estimated market share of approximately 21.17%. The company has gained outstanding sale through providing palmoplantar pustulosis (PPP) treatment.
- In January 2019, Novartis AG received positive result from the phase III clinical trial of Cosentyx in order to treat patients with moderate to severe forms of plaque psoriasis. As palmoplantar pustulosis (PPP) is one of the symptom associated with plaque psoriasis, this product is also used for treatment of inflammatory conditions. The result obtained thus helped the company to expand its root in palmoplantar pustulosis (PPP) market.
Trends Impacting the Palmoplantar Pustulosis (PPP) Market
Now the question is which other regions Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), AbbVie Inc. and Novartis AG are targeting? Data Bridge Market Research has estimated a large growth in the U.S. palmoplantar pustulosis (PPP) market and the market leaders targeting the U.S. to be their next revenue pockets for 2020.
The palmoplantar pustulosis (PPP) market is becoming more competitive with companies such as Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.), AbbVie Inc. and Novartis AG as they are the top dominating companies in the U.S. palmoplantar pustulosis (PPP) market having maximum number of products. Data Bridge Market Research new reports highlight the major growth factors and opportunities in the U.S. palmoplantar pustulosis (PPP) market.
For more analysis on the U.S. palmoplantar pustulosis (PPP) market request for a briefing with our analysts https://www.databridgemarketresearch.com/speak-to-analyst/?dbmr=us-palmoplantar-pustulosis-ppp-market
The U.S. Palmoplantar Pustulosis (PPP) Market Development
- In July 2020, Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.) received the U.S. FDA approval for stelara (ustekinumab). The approval proved that the drug has the capability to target (IL)-12 and IL-23 interleukin responsible to induce overactive inflammatory response. This approval thus paved the way for the company to sale its product in order to treat palmoplantar pustulosis (PPP) which in turn boosted the company’s revenue.
Scope of the U.S. Palmoplantar Pustulosis (PPP) Market
All country-based analysis of the U.S. palmoplantar pustulosis (PPP) market is further analyzed based on further segmentation. On the basis of disease type, the U.S. palmoplantar pustulosis (PPP) market is segmented into type A, and type B. On the basis of severity, the U.S. palmoplantar pustulosis (PPP) market is segmented into mild-moderate and moderate-severe. On the basis of type, the U.S. palmoplantar pustulosis (PPP) market is segmented into diagnosis and treatment. On the basis of population type, the U.S. palmoplantar pustulosis (PPP) market is segmented into children and adults. On the basis of route of administration, the U.S. palmoplantar pustulosis (PPP) market is segmented into oral, topical and parenteral. On the basis of end user, the U.S. palmoplantar pustulosis (PPP) market is segmented into hospitals, specialty clinics, diagnostic centers and home healthcare. On the basis of distribution channel, the U.S. palmoplantar pustulosis (PPP) market is segmented into direct tender, hospital pharmacies, retail pharmacies and online pharmacies.
To know more about the study https://www.databridgemarketresearch.com/reports/us-palmoplantar-pustulosis-ppp-market
Key Pointers Covered in the U.S. Palmoplantar Pustulosis (PPP) Market Industry Trends and Forecast to 2027
- Market Size
- Top to Bottom Market Analysis
- Recent Developments for Market Competitors
- Recent Market Value for Different Countries
- Market Value and Over View of Market
- Company Profiling of Top Eight Players of Market
Key Market Competitors Covered in the Report
The key market players for the U.S. palmoplantar pustulosis (PPP) market are listed below:
- ANAPTYSBIO, INC.
- Novartis AG
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Amgen Inc.
- Janssen Pharmaceuticals, Inc. (a subsidiary of Johnson & Johnson Services, Inc.)
- AbbVie Inc.
- Bristol-Myers Squibb Company
- Aristea Therapeutics
- Perrigo Company plc
- Ingenus Pharmaceuticals
- Zydus Pharmaceuticals, Inc. (a subsidiary of Zydus Cadila)
- Teva Pharmaceutical USA (a subsidiary of Teva Pharmaceutical Industries Ltd.)
- F. Hoffmann-La Roche Ltd
- Cosette Pharmaceuticals, Inc.
- WOCKHARDT
- Teligent
- Lupin Pharmaceuticals, Inc. (a subsidiary of LUPIN)
- sanofi-aventis U.S. LLC (a subsidiary of Sanofi)
- Bausch Health Companies Inc.
- Mylan N.V.
- The Daavlin Company
- Glenmark Pharmaceutical Inc., USA (a subsidiary of Glenmark Pharmaceutical Inc.)
- ALEOR Dermaceuticals Limited
- Akorn, Incorporated
- Tolmar Pharmaceuticals, Inc.
- Encore Dermatology, Inc.
- Sigmapharm Laboratories, LLC
- GlaxoSmithKline plc
- Amneal Pharmaceuticals LLC
- Encube Ethicals
Above are the key players covered in the report, to know about more and exhaustive list of the U.S. palmoplantar pustulosis (PPP) companies’, contact us https://www.databridgemarketresearch.com/toc/?dbmr=us-palmoplantar-pustulosis-ppp-market
Research Methodology: The U.S. Palmoplantar Pustulosis (PPP) Market
Data collection and base year analysis is done using data collection modules with large sample sizes. The market data is analysed and forecasted using market statistical and coherent models. Also market share analysis and key trend analysis are the major success factors in the market report. To know more please request an analyst call or can drop down your enquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market, and primary (industry expert) validation. Apart from this, data models include vendor positioning grid, market time line analysis, market overview and guide, company positioning grid, company market share analysis, standards of measurement, top to bottom analysis and vendor share analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Primary Respondents
- Demand Side: Pharmacists, Hospitals, Clinicians and Technicians, Dermatologists, Academic Professionals and Researchers
- Supply Side: Product Managers, Marketing Managers, C-Level Executives, Distributors, Market Intelligence and Regulatory Affairs Managers among others.
Related Reports
- Global Psoriasis Treatment Market - Industry Trends and Forecast to 2027
- Global Plaque Psoriasis Market - Industry Trends and Forecast to 2027
- Global Anti-Inflammatory Therapeutics Market - Industry Trends and Forecast to 2027
Browse in Healthcare Category Related Reports@ https://www.databridgemarketresearch.com/report-category/healthcare/
